New injection LAE102 enters human safety trials for weight control
NCT ID NCT06493084
First seen Nov 17, 2025 · Last updated May 23, 2026 · Updated 28 times
Summary
This early-stage study tests a new injection called LAE102 to see if it is safe and how the body processes it. The trial involves 160 healthy and overweight/obese adults aged 18 to 65. Researchers will monitor side effects and measure drug levels in the blood to gather initial safety data.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for OVERWEIGHT AND OBESE VOLUNTEERS are added.
Genom att skicka in godkänner du våra Användarvillkor
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
Genom att skicka in godkänner du våra Användarvillkor
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
Locations
-
Fudan Zhongshan Hospital
RECRUITINGShanghai, Shanghai Municipality, 201203, China
Contact Email: •••••@•••••
Conditions
Explore the condition pages connected to this study.